1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Selenko, P.
Gregorovic, G.
Sprangers, R.
Stier, G.
Rhani, Z.
Kramer, A.
Sattler, M.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Mol.Cell
MOCEFL
2168
1097-2765
11
965
976
10.1016/S1097-2765(03)00115-1
12718882
Structural basis for the molecular recognition between human splicing factors U2AF65 and SF1/mBBP
2003
10.2210/pdb1opi/pdb
pdb_00001opi
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
SINGLE WAVELENGTH
M
1
1.0
11976.615
SPLICING FACTOR U2AF 65 KDA SUBUNIT
C-TERMINAL RRM DOMAIN
1
man
polymer
1691.936
SPLICING FACTOR SF1
N-TERMINAL PEPTIDE
1
syn
polymer
U2 AUXILIARY FACTOR 65 KDA SUBUNIT, U2 SNRNP AUXILIARY FACTOR LARGE SUBUNIT, HU2AF(65)
no
no
GHPTEVLCLMNMVLPEELLDDEEYEEIVEDVRDECSKYGLVKSIEIPRPVDGVEVPGCGKIFVEFTSVFDCQKAMQGLTG
RKFANRVVVTKYCDPDSYHRRDFW
GHPTEVLCLMNMVLPEELLDDEEYEEIVEDVRDECSKYGLVKSIEIPRPVDGVEVPGCGKIFVEFTSVFDCQKAMQGLTG
RKFANRVVVTKYCDPDSYHRRDFW
A
polypeptide(L)
no
no
PSKKRKRSRWNQD
PSKKRKRSRWNQD
B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Escherichia
Escherichia coli
sample
9606
Homo sapiens
469008
Escherichia coli BL21(DE3)
BL21 DE3
PLASMID
MODIFIED PET24D
database_2
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
1
0
2004-03-16
1
1
2008-04-29
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
THE UNREFINED NMR ENSEMBLE OF THE SAME PROTEIN COMPLEX
RCSB
Y
RCSB
2003-03-05
REL
THE PEPTIDE WAS CHEMICALLY SYNTHESIZED AND DERIVED FROM THE N-TERMINUS OF SF1. THE SEQUENCE OF THE PEPTIDE IS NATURALLY FOUND IN HOMO SAPIENS (HUMAN).
sample
STRUCTURES WITH THE LEAST RESTRAINT VIOLATIONS, STRUCTURES WITH THE LOWEST ENERGY
100
10
3D_13C-SEPARATED_NOESY
3D_ 15N-SEPARATED_NOESY
3D_13C/15N-EDITED/FILTERED_NOESY
50mM SALT
6.4
AMBIENT
295
K
REFINEMENT OF PROTEIN STRUCTURES IN WATER SOLVENT, ACCORDING TO LINGE ET AL. (PROTEINS 50:496 -506, 2003)
RESTRAINED MOLECULAR DYNAMICS USING CNS AND ARIA FOR AMBIGUOUS DISTANCE RESTRAINTS
1
lowest energy
1MM 15N,13C U2AF65-RRM3 + 1MM UNLABELED SF1_10-25, 30MM PHOSPHATE BUFFER, 20MM NACL, 3MM DTT
D2O
BRUNGER
refinement
CNS
1.1
NILGES
refinement
ARIA
1.2
600
Bruker
DRX
500
Bruker
DRX
800
Bruker
DRX
GLY
372
n
1
GLY
372
A
HIS
373
n
2
HIS
373
A
PRO
374
n
3
PRO
374
A
THR
375
n
4
THR
375
A
GLU
376
n
5
GLU
376
A
VAL
377
n
6
VAL
377
A
LEU
378
n
7
LEU
378
A
CYS
379
n
8
CYS
379
A
LEU
380
n
9
LEU
380
A
MET
381
n
10
MET
381
A
ASN
382
n
11
ASN
382
A
MET
383
n
12
MET
383
A
VAL
384
n
13
VAL
384
A
LEU
385
n
14
LEU
385
A
PRO
386
n
15
PRO
386
A
GLU
387
n
16
GLU
387
A
GLU
388
n
17
GLU
388
A
LEU
389
n
18
LEU
389
A
LEU
390
n
19
LEU
390
A
ASP
391
n
20
ASP
391
A
ASP
392
n
21
ASP
392
A
GLU
393
n
22
GLU
393
A
GLU
394
n
23
GLU
394
A
TYR
395
n
24
TYR
395
A
GLU
396
n
25
GLU
396
A
GLU
397
n
26
GLU
397
A
ILE
398
n
27
ILE
398
A
VAL
399
n
28
VAL
399
A
GLU
400
n
29
GLU
400
A
ASP
401
n
30
ASP
401
A
VAL
402
n
31
VAL
402
A
ARG
403
n
32
ARG
403
A
ASP
404
n
33
ASP
404
A
GLU
405
n
34
GLU
405
A
CYS
406
n
35
CYS
406
A
SER
407
n
36
SER
407
A
LYS
408
n
37
LYS
408
A
TYR
409
n
38
TYR
409
A
GLY
410
n
39
GLY
410
A
LEU
411
n
40
LEU
411
A
VAL
412
n
41
VAL
412
A
LYS
413
n
42
LYS
413
A
SER
414
n
43
SER
414
A
ILE
415
n
44
ILE
415
A
GLU
416
n
45
GLU
416
A
ILE
417
n
46
ILE
417
A
PRO
418
n
47
PRO
418
A
ARG
419
n
48
ARG
419
A
PRO
420
n
49
PRO
420
A
VAL
421
n
50
VAL
421
A
ASP
422
n
51
ASP
422
A
GLY
423
n
52
GLY
423
A
VAL
424
n
53
VAL
424
A
GLU
425
n
54
GLU
425
A
VAL
426
n
55
VAL
426
A
PRO
427
n
56
PRO
427
A
GLY
428
n
57
GLY
428
A
CYS
429
n
58
CYS
429
A
GLY
430
n
59
GLY
430
A
LYS
431
n
60
LYS
431
A
ILE
432
n
61
ILE
432
A
PHE
433
n
62
PHE
433
A
VAL
434
n
63
VAL
434
A
GLU
435
n
64
GLU
435
A
PHE
436
n
65
PHE
436
A
THR
437
n
66
THR
437
A
SER
438
n
67
SER
438
A
VAL
439
n
68
VAL
439
A
PHE
440
n
69
PHE
440
A
ASP
441
n
70
ASP
441
A
CYS
442
n
71
CYS
442
A
GLN
443
n
72
GLN
443
A
LYS
444
n
73
LYS
444
A
ALA
445
n
74
ALA
445
A
MET
446
n
75
MET
446
A
GLN
447
n
76
GLN
447
A
GLY
448
n
77
GLY
448
A
LEU
449
n
78
LEU
449
A
THR
450
n
79
THR
450
A
GLY
451
n
80
GLY
451
A
ARG
452
n
81
ARG
452
A
LYS
453
n
82
LYS
453
A
PHE
454
n
83
PHE
454
A
ALA
455
n
84
ALA
455
A
ASN
456
n
85
ASN
456
A
ARG
457
n
86
ARG
457
A
VAL
458
n
87
VAL
458
A
VAL
459
n
88
VAL
459
A
VAL
460
n
89
VAL
460
A
THR
461
n
90
THR
461
A
LYS
462
n
91
LYS
462
A
TYR
463
n
92
TYR
463
A
CYS
464
n
93
CYS
464
A
ASP
465
n
94
ASP
465
A
PRO
466
n
95
PRO
466
A
ASP
467
n
96
ASP
467
A
SER
468
n
97
SER
468
A
TYR
469
n
98
TYR
469
A
HIS
470
n
99
HIS
470
A
ARG
471
n
100
ARG
471
A
ARG
472
n
101
ARG
472
A
ASP
473
n
102
ASP
473
A
PHE
474
n
103
PHE
474
A
TRP
475
n
104
TRP
475
A
PRO
13
n
1
PRO
13
B
SER
14
n
2
SER
14
B
LYS
15
n
3
LYS
15
B
LYS
16
n
4
LYS
16
B
ARG
17
n
5
ARG
17
B
LYS
18
n
6
LYS
18
B
ARG
19
n
7
ARG
19
B
SER
20
n
8
SER
20
B
ARG
21
n
9
ARG
21
B
TRP
22
n
10
TRP
22
B
ASN
23
n
11
ASN
23
B
GLN
24
n
12
GLN
24
B
ASP
25
n
13
ASP
25
B
author_defined_assembly
2
dimeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
SER
414
A
N
SER
43
A
O
GLU
435
A
O
GLU
64
A
O
ILE
432
A
O
ILE
61
A
N
LEU
380
A
N
LEU
9
A
N
CYS
379
A
N
CYS
8
A
O
LYS
462
A
O
LYS
91
1
A
HIS
373
-173.91
113.69
1
A
THR
375
-114.78
-71.27
1
A
GLU
376
-176.87
-45.91
1
A
MET
383
-164.89
14.45
1
A
LEU
389
-82.87
34.85
1
A
SER
407
-90.03
30.33
1
A
PRO
427
-66.29
77.05
1
A
ARG
452
-74.80
-152.21
1
A
LYS
453
-160.84
117.03
1
A
ALA
455
-161.18
-50.85
1
A
ASN
456
-157.24
24.95
1
A
PHE
474
63.49
105.96
1
B
SER
14
-102.06
-166.76
1
B
LYS
18
-163.85
-54.25
1
B
TRP
22
-142.02
53.09
1
B
ASN
23
-80.23
-156.53
1
B
GLN
24
-169.32
-37.71
2
A
HIS
373
-176.19
98.48
2
A
GLU
376
-176.24
-45.92
2
A
LEU
389
-86.54
37.73
2
A
PRO
418
-47.07
157.52
2
A
GLU
425
-92.19
35.15
2
A
PRO
427
-65.53
80.51
2
A
ARG
452
-74.05
-164.76
2
A
ALA
455
-157.71
-49.77
2
A
ASN
456
-160.23
23.68
2
A
ASP
467
-63.13
-78.66
2
A
PHE
474
-81.44
-90.34
2
B
SER
14
56.69
-96.58
2
B
LYS
15
-159.78
-25.31
2
B
ARG
19
-164.16
-61.19
2
B
SER
20
60.14
102.81
2
B
TRP
22
57.68
91.98
3
A
HIS
373
66.47
136.39
3
A
THR
375
-100.37
-76.40
3
A
GLU
376
-175.43
-43.05
3
A
LEU
389
-83.53
40.90
3
A
SER
407
-90.35
31.58
3
A
PRO
418
-42.58
152.72
3
A
GLU
425
-89.69
34.25
3
A
PRO
427
-66.41
76.94
3
A
ARG
452
-108.22
-162.00
3
A
ALA
455
-152.24
62.56
3
B
ARG
21
62.37
162.51
3
B
TRP
22
53.71
90.99
4
A
THR
375
-101.55
-77.53
4
A
GLU
376
-175.68
-45.78
4
A
LEU
389
-85.98
38.74
4
A
SER
407
-90.07
31.01
4
A
PRO
420
-30.80
125.93
4
A
VAL
421
-60.35
96.14
4
A
ASP
422
56.38
17.62
4
A
VAL
424
-93.53
-82.40
4
A
PRO
427
-97.75
44.86
4
A
ARG
452
-83.88
-152.02
4
A
ALA
455
-160.48
-41.27
4
A
ASN
456
-164.98
22.80
4
A
PHE
474
61.52
105.22
4
B
LYS
16
-142.31
-47.69
4
B
LYS
18
61.29
105.37
4
B
ARG
19
57.27
77.25
4
B
ASN
23
-77.26
-161.74
4
B
GLN
24
-172.96
-36.69
5
A
THR
375
-107.83
-71.34
5
A
GLU
376
-178.11
-45.57
5
A
MET
383
-165.61
20.78
5
A
LEU
389
-86.32
40.89
5
A
SER
414
-170.86
146.93
5
A
PRO
427
-94.03
36.73
5
A
CYS
429
-55.16
106.16
5
A
LYS
453
-34.31
116.82
5
A
ALA
455
-152.40
-42.99
5
A
ASN
456
-170.67
36.13
5
A
VAL
458
-50.20
103.44
5
A
ASP
467
-64.90
-74.62
5
B
SER
14
-143.55
-72.22
5
B
LYS
15
-151.80
22.96
5
B
SER
20
-154.32
-50.75
5
B
TRP
22
64.33
126.55
6
A
HIS
373
-174.87
117.39
6
A
THR
375
-107.61
-69.19
6
A
GLU
376
-178.29
-46.30
6
A
MET
383
-157.59
11.44
6
A
LEU
389
-87.96
32.70
6
A
SER
407
-90.52
32.66
6
A
VAL
421
-57.75
94.71
6
A
ASP
422
57.45
16.66
6
A
VAL
424
-98.67
-89.44
6
A
GLN
447
-69.33
2.07
6
A
ARG
452
-90.04
-142.66
6
A
ALA
455
-168.59
-40.17
6
A
ASN
456
-153.93
-22.58
6
A
PHE
474
63.25
107.44
6
B
ASN
23
-112.12
-167.21
6
B
GLN
24
-178.50
-58.63
7
A
PRO
374
-43.40
100.66
7
A
THR
375
-102.01
-70.25
7
A
GLU
376
-177.65
-43.09
7
A
MET
383
-167.89
19.67
7
A
LEU
389
-86.13
35.27
7
A
ASP
422
57.16
17.81
7
A
VAL
424
-90.06
-85.94
7
A
GLU
425
-69.18
95.01
7
A
PRO
427
-92.54
36.81
7
A
ARG
452
-112.42
-146.97
7
A
LYS
453
-177.00
110.25
7
A
ALA
455
-173.00
-52.39
7
A
ASN
456
-152.87
6.96
7
A
ASP
467
-59.95
-80.54
7
A
PHE
474
-56.90
-80.10
7
B
LYS
15
-126.95
-72.36
7
B
LYS
16
-151.48
-56.14
7
B
SER
20
-143.85
-153.71
7
B
ARG
21
65.30
119.77
7
B
TRP
22
55.99
83.00
8
A
PRO
374
-39.69
100.26
8
A
THR
375
-98.42
-70.97
8
A
GLU
376
-176.90
-45.47
8
A
LEU
389
-85.64
34.56
8
A
LEU
390
-133.84
-35.85
8
A
PRO
418
-42.00
151.78
8
A
PRO
427
-66.34
82.14
8
A
ARG
452
-69.10
-167.07
8
A
ASP
467
-64.94
-71.51
8
A
PHE
474
64.53
108.84
8
B
SER
14
62.45
177.77
8
B
ARG
19
-111.34
-106.81
8
B
SER
20
55.00
-166.60
8
B
ARG
21
62.58
113.28
8
B
TRP
22
57.10
84.05
8
B
GLN
24
74.72
-59.98
9
A
HIS
373
179.63
102.66
9
A
THR
375
-134.70
-76.99
9
A
GLU
376
-178.54
-46.92
9
A
LEU
389
-93.64
32.61
9
A
SER
407
-90.13
32.04
9
A
ASP
422
56.75
19.76
9
A
VAL
424
-86.35
-71.09
9
A
VAL
426
-119.42
68.18
9
A
PRO
427
-94.96
35.29
9
A
GLN
447
-69.68
2.87
9
A
ARG
452
-78.56
-144.80
9
A
ALA
455
-165.34
-39.47
9
A
ASN
456
-164.47
14.09
9
A
ASP
467
-78.09
-75.59
9
A
PHE
474
-90.32
-78.92
9
B
SER
14
61.35
175.75
9
B
LYS
16
-146.59
-12.14
9
B
ARG
19
39.00
38.86
9
B
TRP
22
53.04
70.22
9
B
ASN
23
-75.90
-160.41
10
A
MET
383
-148.33
12.79
10
A
LEU
389
-99.25
33.14
10
A
LYS
413
-55.94
-72.42
10
A
PRO
418
-35.67
147.55
10
A
ASP
422
57.00
17.93
10
A
VAL
424
-94.66
-80.58
10
A
GLU
425
-66.63
84.38
10
A
PRO
427
-91.62
34.46
10
A
LYS
453
-35.39
118.37
10
A
ALA
455
-158.63
67.76
10
A
ASP
467
-58.78
-81.72
10
A
PHE
474
64.15
105.72
10
B
SER
14
-84.22
-156.56
10
B
LYS
16
-161.71
-29.11
10
B
ARG
17
-111.07
-164.82
10
B
LYS
18
-73.79
-169.37
10
B
ARG
21
63.10
161.86
10
B
TRP
22
56.48
90.02
SOLUTION STRUCTURE OF THE THIRD RNA RECOGNITION MOTIF (RRM) OF U2AF65 IN COMPLEX WITH AN N-TERMINAL SF1 PEPTIDE
1
N
N
2
N
N
A
ASP
391
A
ASP
20
HELX_P
A
SER
407
A
SER
36
1
1
17
A
SER
438
A
SER
67
HELX_P
A
THR
450
A
THR
79
1
2
13
A
ASP
465
A
ASP
94
HELX_P
A
ARG
471
A
ARG
100
1
3
7
RNA BINDING PROTEIN
NON-CANONICAL RNA RECOGNITION MOTIF, 4-STRANDED ANTI-PARALLEL BETA-SHEET, 2 ALPHA HELICES ADDITIONALLY EXTENDED BY A THIRD HELIX C, RNA BINDING PROTEIN
U2AF2_HUMAN
UNP
1
372
P26368
GHPTEVLCLMNMVLPEELLDDEEYEEIVEDVRDECSKYGLVKSIEIPRPVDGVEVPGCGKIFVEFTSVFDCQKAMQGLTG
RKFANRVVVTKYCDPDSYHRRDFW
SF01_HUMAN
UNP
2
13
Q15637
PSKKRKRSRWNQD
372
475
1OPI
372
475
P26368
A
1
1
104
13
25
1OPI
13
25
Q15637
B
2
1
13
4
anti-parallel
anti-parallel
anti-parallel
A
VAL
412
A
VAL
41
A
GLU
416
A
GLU
45
A
LYS
431
A
LYS
60
A
PHE
436
A
PHE
65
A
VAL
377
A
VAL
6
A
MET
381
A
MET
10
A
VAL
460
A
VAL
89
A
CYS
464
A
CYS
93
1
P 1